- AU$22.59m
- AU$26.83m
- AU$12.46m
Brief: Althea Group Says Althea THC20 CBD1 Approved For Sale In Ireland
Australia's Althea Group jumps on cannabis product approval in UK
Brief: Althea Says Uk Public Health Approved Althea Cbd10Thc5 For Uk Patients
Australia's Althea Group soars most in 9 months on operating profit forecast
Brief: Althea Group Expects To Report Substantially Improved Cash Flow Position For Q4
Brief: Althea Group Says HY Net Loss After Tax A$9.4 Million
Brief: Althea Group Says It Secures A$2.2 Mln Funding Via Convertible Notes
Australia's Althea Group leaps on securing debt funding
Brief: Althea Group Anticipates Achieving Cashflow Breakeven & Operating Profitability During March 2023
Brief: Althea Group Holdings Says Secures New C$2 Million Loan Facility
Brief: Althea Group Holdings Says Well Positioned To Achieve Operating Profitability In Q3 Fy23
Brief: Althea Group Signs A Non-Binding MoU With Nimbus Health GmbH
Australia's Althea hits 4-month low on discounted placement
Brief: Althea Group Holdings Seeks Trading Halt
Australia's Althea jumps on cannabis product approval in Ireland
Brief: Althea Group Says Authority Approved Medicinal Cannabis Product For Supply In Ireland
Australia Stock Exchange release from ALTHEA GROUP HOL : Disregard Changes in substantial holding
Australia Stock Exchange release from ALTHEA GROUP HOL : Change in substantial holding
Australia Stock Exchange release from ALTHEA GROUP HOL : Change in substantial holding